Cargando…
New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease
Cerebrospinal fluid (CSF) biomarkers based on the core pathological proteins associated with Alzheimer’s disease (AD), i.e., amyloid-β (Aβ) and tau protein, are widely regarded as useful diagnostic biomarkers. However, a lack of biomarkers for monitoring the treatment response and indexing clinical...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210893/ https://www.ncbi.nlm.nih.gov/pubmed/32284537 http://dx.doi.org/10.1038/s12276-020-0418-9 |